Revolutionizing reproductive medicine through cutting-edge PGT techniques
Dr Razan Jawdat is a renowned scientist at King Faisal Specialist Hospital & Research Centre (KFSHRC), specialising in reproductive genetics. With a background in molecular genetics, her work focuses on Preimplantation Genetic Testing (PGT). This cutting-edge technique enhances reproductive outcomes and prevents hereditary diseases. Dr. Jawdat’s expertise in genomic testing at the embryology level has placed KFSHRC at the forefront of reproductive medicine, ensuring healthier future generations.
Her work is particularly impactful in regions with high consanguinity, where the prevalence of genetic disorders is significantly elevated. By integrating Single Nucleotide Polymorphisms (SNP) array analysis by key mapping and next-generation sequencing technology into IVF protocols, she has contributed to the refinement of genetic screening techniques, reducing the burden of inherited conditions. Her work supports families facing repeated pregnancy loss for unknown reasons and genetic risks, empowering them with precise reproductive choices.
With her contribution, KFSHRC has established itself as a centre of excellence in reproductive health and genetic medicine, which aligns with Saudi Arabia’s Vision 2030 healthcare objectives. Through her and her team’s pioneering efforts, the institution has gained national and international recognition as a leader in genomic medicine and IVF. Dr. Jawdat’s clinical focus ensures that PGT is applied selectively to cases such as Recurrent Implantation Failure (RIF) of unknown causes and Repeated Miscarriages (RM), maximizing its efficacy through an evidence-based approach.
Her colleagues at KFSHRC include a wide range of IVF consultants, embryologists, PGT technologists, and clinical scientists, including Dr Wafa Qubbaj and Dr Serdar Coskun. Their collective expertise has progressed the field of reproductive genetics, establishing new benchmarks in patient care and scientific advancement. Additionally, her work goes beyond clinical applications to include training programs and academic initiatives to foster local expertise in genetics at the preimplantation stages.
Committed to driving advancements in reproductive genetics, Dr. Jawdat actively collaborates with leading global research institutions to refine methodologies and improve patient outcomes. Her participation in international conferences reflects her dedication to knowledge-sharing and interdisciplinary cooperation. At LEAP 2025, she underscored the transformative role of PGT, particularly in addressing the challenges of inherited disorders in consanguineous populations, reinforcing the importance of genetic innovations in reproductive medicine.
Dr. Jawdat envisions a future where Saudi Arabia continues to lead in genomic medicine, ensuring that PGT is more accessible and sustainable. Her work aligns with the country’s long-term healthcare objectives, driving precision medicine and genetic counselling advancements. “No family should have to face the uncertainty of genetic disease, repeated pregnancy loss, or unexplained implantation failure without answers. PGT empowers families with solutions—helping them select the healthiest embryos for a successful pregnancy. Carrier screening before pregnancy is essential, especially for consanguineous couples, to identify risks early and make informed choices. With these advances, we are not just improving fertility care—we are shaping a future of healthier generations.”
